Title : Nordihydroguaiaretic acid (NDGA), an inhibitor of the HER2 and IGF-1 receptor tyrosine kinases, blocks the growth of HER2-overexpressing human breast cancer cells.

Pub. Date : 2008 Feb 1

PMID : 17562544






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Nordihydroguaiaretic acid (NDGA), an inhibitor of the HER2 and IGF-1 receptor tyrosine kinases, blocks the growth of HER2-overexpressing human breast cancer cells. Masoprocol insulin like growth factor 1 receptor Homo sapiens
2 Nordihydroguaiaretic acid (NDGA), an inhibitor of the HER2 and IGF-1 receptor tyrosine kinases, blocks the growth of HER2-overexpressing human breast cancer cells. Masoprocol insulin like growth factor 1 receptor Homo sapiens
3 We have reported that nordihydroguaiaretic acid (NDGA) inhibits the tyrosine kinase activities of the IGF-1 receptor (IGF-1R) and the HER2 receptor in breast cancer cells. Masoprocol insulin like growth factor 1 receptor Homo sapiens
4 We have reported that nordihydroguaiaretic acid (NDGA) inhibits the tyrosine kinase activities of the IGF-1 receptor (IGF-1R) and the HER2 receptor in breast cancer cells. Masoprocol insulin like growth factor 1 receptor Homo sapiens
5 We have reported that nordihydroguaiaretic acid (NDGA) inhibits the tyrosine kinase activities of the IGF-1 receptor (IGF-1R) and the HER2 receptor in breast cancer cells. Masoprocol insulin like growth factor 1 receptor Homo sapiens
6 We have reported that nordihydroguaiaretic acid (NDGA) inhibits the tyrosine kinase activities of the IGF-1 receptor (IGF-1R) and the HER2 receptor in breast cancer cells. Masoprocol insulin like growth factor 1 receptor Homo sapiens